Fenwick represented SyntheX on the deal.SyntheX, a biotechnology company innovating next-generation functional drug discovery engines, announced its research collaboration and license agreement with Bristol Myers Squibb…
SyntheX’s Research Collaboration with Bristol Myers Squibb
